Vp. Korhonen et al., EXPRESSION OF BOVINE BETA-LACTOGLOBULIN HUMAN ERYTHROPOIETIN FUSION PROTEIN IN THE MILK OF TRANSGENIC MICE AND RABBITS, European journal of biochemistry, 245(2), 1997, pp. 482-489
We have generated several transgenic mouse lines and rabbits expressin
g efficiently (up to 0.3 mg/ml in mice and up to 0.5 mg/ml in rabbits)
human erythropoietin in their milk as bovine beta-lactoglobulin fusio
n protein. Human erythropoietin cDNA was inserted in frame into exon 5
of the bovine beta-lactoglobulin gene with a linker oligonucleotide e
ncoding the cleavage site for bacterial IgA protease. RNA analysis per
formed on one lactating transgenic mouse and one transgenic rabbit rev
ealed that the fusion gene was expressed almost exlusively in the mamm
ary gland, although low amounts of transgene-derived RNA were detectab
le in salivary glands and uterus or in the kidney. The fusion protein
was specifically cleaved with IgA protease. The erythropoietin part ob
tained upon digestion had a lower molecular mass than recombinant eryt
hropoietin produced in Chinese hamster ovary cells. By deglycosylation
analysis it was shown that the difference in size was due to a differ
ent type of glycosylation. Biological activity of the fusion protein,
as determined by growth stimulation of TF-1 erythroleukemia cells, was
less than 15% of that of human recombinant erythropoietin. Upon diges
tion of the fusion protein with IgA proteose, biological activity comp
arable to that of the recombinant erythropoietin was recovered. Transg
enic males and virgin females did not show signs of enhanced erythropo
iesis, but lactating females expressing the transgene displayed transi
ent increases in their hematocrit values.